TITLE

A pilot seroepidemiological study of cytomegalovirus infection in women of child bearing age

AUTHOR(S)
Sheevani; Jindal, N.; Aggarwal, A.
PUB. DATE
January 2005
SOURCE
Indian Journal of Medical Microbiology;Jan2005, Vol. 23 Issue 1, p34
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Three hundred and forty serum samples collected from women of child bearing age, without any clinical evidence of cytomegalovirus (CMV) infection, were screened for the presence of IgG antibodies against CMV by ELISA test. The IgG antibodies were detected in 297 which gave prevalence rate of 87.4%. Significantly higher prevalence rates (p < 0.001) were observed with increasing age and with increase in parity. There was significant difference in the antibody prevalence in different socioeconomic groups. Seroprevalence rate was also found to be more in women from rural area than those from urban area, although the difference was statistically not significant (p > 0.05). Marital status showed no impact upon the seroprevalence of IgG antibodies in women.
ACCESSION #
18078103

 

Related Articles

  • Ability of Three IgG-Avidity Assays to Exclude Recent Cytomegalovirus Infection. Bodéus, M.; Beulné, D.; Goubau, P. // European Journal of Clinical Microbiology & Infectious Diseases;Apr2001, Vol. 20 Issue 4, p248 

    At present, the measurement of IgG avidity appears to be the best method for differentiating primary from nonprimary cytomegalovirus (CMV) infection. This study compared the performances of three denaturation assays for the measurement of CMV IgG avidity: an in-house method and the commercially...

  • Valganciclovir for treatment of congenital cytomegalovirus infection. Schulzke, Sven; Bührer, Christoph; Bührer, Christoph // European Journal of Pediatrics;Aug2006, Vol. 165 Issue 8, p575 

    Describes the case of a term newborn girl with symptomatic cytomegalovirus (CMV) infection. Medical history of the patient; Symptoms presented; Relationship between valganciclovir dose and serum levels.

  • Cytomegalovirus encephalitis in an immunocompetent pregnant woman. Saliba, W. R.; Raz, R.; Keness, Y.; Goldstein, L. H.; Reshef, A.; Elias, M. // European Journal of Clinical Microbiology & Infectious Diseases;Jul2004, Vol. 23 Issue 7, p563 

    Presented here is the case of an immunocompetent pregnant woman with probable cytomegalovirus encephalitis. The clinical picture was characterized by diffuse headache, drowsiness and the development of an acute confused state. Diagnosis was based on the documentation of recent cytomegalovirus...

  • Seroprevalence of Cytomegalovirus Infection in the United States, 1988-1994. Staras, Stephanie A. S.; Dollard, Sheila C.; Radford, Kay W.; Flanders, W. Dana; Pass, Robert F.; Cannon, Michael J. // Clinical Infectious Diseases;11/1/2006, Vol. 43 Issue 9, p1143 

    Background. Cytomegalovirus (CMV) is a leading cause of congenital illness and disability, including hearing loss and mental retardation. However, there are no nationwide estimates of CMV seroprevalence among pregnant women or the overall population of the United States. Methods. To determine...

  • Breast cancer, cytomegalovirus and Epstein–Barr virus: a nested case–control study. Cox, B.; Richardson, A.; Graham, P.; Gislefoss, R. E.; Jellum, E.; Rollag, H. // British Journal of Cancer;5/25/2010, Vol. 102 Issue 11, p1665 

    Background:We investigated whether elevation in serum cytomegalovirus (CMV) or Epstein–Barr virus (EBV) immunoglobulin G (IgG) antibody levels precedes the development of breast cancer.Methods:A nested case–control study was carried out within the Janus Serum Bank cohort. Two serum...

  • Immunologic Abnormalities Induced by Postperfusion Cytomegalovirus Infection. Kantor, Gary L.; Goldberg, Leonard S.; Johnson, B. Lamar; Derechin, Michael M.; Barnett, Eugene V. // Annals of Internal Medicine;Oct70, Vol. 73 Issue 4, p553 

    Focuses on a study that investigated clinical and immunologic features in a number of patients with cytomegalovirus-induced postperfusion syndrome. Materials and methods; Results; Discussion.

  • Disseminated Cytomegalovirus Disease in Hosts without Acquired Immunodeficiency Syndrome and without an Organ Transplant. Kanno, Mettassebia; Chandrasekar, Pranatharthi H.; Alangaden, George J.; Bentley, Gail; Vander Heide, Richard S. // Clinical Infectious Diseases;1/15/2001, Vol. 32 Issue 2, p313 

    Examines cases of cytomegalovirus disease in patients without HIV and without organ transplants. Diagnosis; Description of the patients; Treatment.

  • Detection of Cytomegalovirus (CMV) DNA by Polymerase Chain Reaction Is Associated with Hearing Loss in Newborns with Symptomatic Congenital CMV Infection Involving the Central Nervous System. Bradford, Russell D.; Cloud, Gretchen; Lakeman, Alfred D.; Boppana, Suresh; Kimberlin, David W.; Jacobs, Richard; Demmler, Gail; Sanchez,, Pablo; Britt, William; Soong, Seng-Jaw; Whitley, Richard J. // Journal of Infectious Diseases;1/15/2005, Vol. 191 Issue 2, p227 

    Objective. The study sought to determine the relationship between cytomegalovirus (CMV) viremia during early infancy and clinical and laboratory outcome events, particularly hearing loss in infants with symptomatic congenital CMV infection involving the central nervous system (CNS). Study...

  • Hearing loss and cytomegalovirus. Strauss, Melvin // Volta Review;Nov97, Vol. 99 Issue 5, p71 

    Focuses on cytomegalovirus as the most common cause of congenital viral induced hearing loss. Maternal infection; Hearing loss in clinically apparent infection and in the asymptomatic infection; Methods of detection; Treatment and prevention; Research efforts related to the disorder.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics